Department of Urology, University of Bologna, S. Orsola-Malpighi Hospital, Via Palagi 9, 40134, Bologna, Italy.
Urolithiasis. 2013 Aug;41(4):347-53. doi: 10.1007/s00240-013-0565-8. Epub 2013 Apr 30.
The objective of the study was to assess the efficacy and safety of tubeless percutaneous nephrolithotomy (t-PCNL) in comparison with standard PCNL (s-PCNL). We retrospectively evaluated 317 consecutive PCNL and compared perioperative results, time of hospitalization and analgesic requirement of t-PCNL (114; 36.0 %) to s-PCNL (203; 64.0 %). The decision to perform a tubeless PCNL was made at the end of the procedures depending on the surgeon's preference and according to the following inclusion criteria: (a) no serious bleeding or perforation in the collecting system during the procedure; (b) patients with no more than one access; and (c) residual stone burden needing a second-stage nephroscopy. Staghorn stones and anatomic anomalies were not considered as exclusion criteria for t-PCNL. Univariate analyses were conducted with one-way ANOVA, Fisher's exact test, Pearson's Chi-square and linear-by-linear association test as appropriate. Stepwise multivariable regression analyses were used to assess the independent correlation between demographics and clinical variables and the clinical outcomes. There were no significant differences between the two groups in terms of stone-free rate, hemoglobin decrease, blood transfusion and complication rate. Mean hospital stay was significantly shorter in the t-PCNL group (3.3 vs. 4.6 days; P < 0.001). Tubeless PCNL was associated with less analgesia requirement (68.4 vs. 86.7 %; P < 0.001) and with lower analgesic dose requirement (1.6 vs. 2.1 mean doses; P = 0.010). Multivariable analyses showed that t-PCNL (P < 0.001), postoperative fever (P < 0.001), transfusions (P < 0.001), operative time (P = 0.002), postoperative hydronephrosis (P = 0.005) and residual fragment dimension (P = 0.024) were independently correlated with duration of hospitalization, while analgesic dose requirement was independently influenced by hemoglobin decrease (P < 0.001), t-PCNL (P = 0.005) and stone number (P = 0.044). Our study confirmed that t-PCNL has similar outcomes to s-PCNL in terms of stone-free rate without increasing complications in selected cases. t-PCNL is a factor independently associated with shorter hospitalization and lower analgesic requirement.
本研究旨在评估无管经皮肾镜取石术(t-PCNL)与标准经皮肾镜取石术(s-PCNL)的疗效和安全性。我们回顾性评估了 317 例连续接受 PCNL 的患者,并比较了 t-PCNL(114 例,36.0%)和 s-PCNL(203 例,64.0%)的围手术期结果、住院时间和镇痛需求。是否进行无管 PCNL 是根据术者的偏好和以下纳入标准在手术结束时决定的:(a)术中收集系统无严重出血或穿孔;(b)患者只有一个通道;(c)残留结石负荷需要二期输尿管镜检查。鹿角结石和解剖异常不被视为 t-PCNL 的排除标准。采用单因素方差分析、Fisher 确切检验、Pearson Chi-square 检验和线性-线性关联检验进行单变量分析。采用逐步多变量回归分析评估人口统计学和临床变量与临床结果之间的独立相关性。两组在结石清除率、血红蛋白下降、输血和并发症发生率方面无显著差异。t-PCNL 组的平均住院时间明显短于 s-PCNL 组(3.3 天比 4.6 天;P<0.001)。t-PCNL 组镇痛需求(68.4%比 86.7%;P<0.001)和镇痛剂量需求(1.6 个平均剂量比 2.1 个平均剂量;P=0.010)均较低。多变量分析显示,t-PCNL(P<0.001)、术后发热(P<0.001)、输血(P<0.001)、手术时间(P=0.002)、术后肾积水(P=0.005)和残石尺寸(P=0.024)与住院时间独立相关,而镇痛剂量需求受血红蛋白下降(P<0.001)、t-PCNL(P=0.005)和结石数量(P=0.044)的影响。我们的研究证实,在选定病例中,t-PCNL 在结石清除率方面与 s-PCNL 相似,且无并发症增加。t-PCNL 是与较短住院时间和较低镇痛需求相关的独立因素。